Who We Are
About Patient Engagement
A Rare Focus
About the Team
About the Team
Passion with a purpose. We love what we do. How could we not?
We partner with our clients and listen to their patients. And why? Because we are all working toward the same common goal: to improve the lives of patients living with rare disease through community, conversation, education and novel therapies. Meet our team!
Cherie Myatt
President, The CM Group
Alexandra Dubois
Vice President, Patient Engagement
Christina Vail
Group Director, Patient Engagement
Mila Woodfield
Director, Patient Strategy & Insights
Patty Duval
Vice President, Compliance & Risk Management
X
Cherie Myatt
President, The CM Group

Cherie Myatt is the President of the CM Group. Prior to launching the company, she spent more than a decade developing marketing and business strategies for pharmaceutical clients at a large Boston-based agency. Driven by an inextinguishable entrepreneurial spirit and recognizing a need for a more individualized, hands-on approach for her clients, Cherie started the CM Group with Maggie Butler in 2005.

The resident visionary, Cherie’s drive for innovation results in new and thoughtful approaches to her clients’ greatest business challenges. e believes that continuing to evolve and diversify agency offerings is critical to helping clients reach their goals in the dynamic life sciences industry. At the end of the day, she’s honored to do meaningful work and help facilitate engagements that allow for human connections and educational exchanges.

Guided by Cherie’s commitment to giving back, the CM Group supports numerous causes and nonprofits, including the Catherine Violet Hubbard Foundation, SNAP (Special Needs Athletic Partnership), Rosie’s Place, and Conquer Cancer. Particularly close to her heart are Team Impact and the N.E. Parkinson’s Foundation, the latter of which she supports with a biking fundraiser each year.

Next
X
Alexandra Dubois
Vice President, Patient Engagement

Alex is the CM Group’s thought leader for patient engagement. A marketer by trade for close to three decades and someone with firsthand patient-advocacy experience, Alex is uniquely equipped to tackle the complexities of patient-centric communications programs at the agency. Under her leadership, the Px Group was established in 2017 as a division of the CM Group focused exclusively on patient engagement.

With her team, she identifies thoughtful ways for life sciences companies to connect on an authentic level with patients and caregivers. Her strategic collaborations have resulted in a variety of powerful programming—from patients engaging with each other to employees connecting with the patient experience. Each engagement is driven by a mission to amplify the patient and caregiver perspective, and in doing so, provide a platform for compassion, empathy, education, and innovation.

Alex’s dedication to important causes carries over into her personal life; she sits on the board of trustees for CARES Foundation, a national organization dedicated to Congenital Adrenal Hyperplasia (CAH), a rare, genetic disorder that affects her youngest son. A roll-up-her-sleeves type, she was also the driving force behind adding essential rescue medicine for patients with adrenal insufficiency to the formulary for ambulances across Massachusetts and New Hampshire.

Next
X
Christina Vail
Group Director, Patient Engagement

Christina brings a decade of Patient Engagement experience to the team, working both on the agency and Client side of the life sciences and biotech industry. She has held leadership roles throughout her tenure working within agencies to help to shape the operational infrastructure not only to support the innerworkings of the business but provide the best work products to clients.

Her experience working in the clinical stage development for multiple gene therapy treatments include the creation of clinical trial materials, ranging from awareness, enrollment, site support and retention resources to fit the needs of each study. In this role, Christina supported the effort in elevating the perspective of rare disease families in the development of patient-centric protocols and study design to ensure optimal experience of participants and their families of gene therapy clinical trials.

Christina has a deep-rooted passion for understanding the patient journey (particularly within rare) and how amplifying the patient voice can educate, motivate and inspire. This passion is infectious, and admired by our clients, team members and the patients with whom we work.

Next
X
Mila Woodfield
Director, Patient Strategy & Insights

With over 10 years of experience uncovering consumer insights, Mila has spent over half of that time within the pharmaceutical and healthcare industry working directly with patients and caregivers to uncover and co-create solutions.

She believes that a true understanding of the patient experience lies not just in the facts, but in a patient’s underlying beliefs, behaviors, and emotions. She identifies and translates key insights into strategies that change behavior across the patient and caregiver journey.

At The Px Group, Mila drives the teams to find the intersection between the needs of life science companies and patient communities. Her approach has driven the creation of innovative programs that drive results for all stakeholders.

Next
X
Next
X
Patty Duval
Vice President, Compliance & Risk Management

With over a decade of compliance and risk management experience, Patty is the agency’s architect and steward of enterprise compliance strategy, structure, and processes, as well as the subject matter expert for clients.

Since joining the CM Group, Patty has established a department that is by the book and informative, and she has assembled an approachable team who is fluent in the latest industry requirements. By launching comprehensive educational and training programs, compliance has moved beyond serving as just an agency resource and instead has been ingrained into the many processes (as well as the hearts and minds) of everyone at the CM Group.

Prior to her focus on compliance, Patty spent two decades taking on a diverse set of roles in product development, marketing and training for medical device companies. Along the way, her guiding light—to improve patient outcomes and experiences—has remained in clear view.

Next
What do our clients say about our team?
"As a Rare Disease marketer, I had the pleasure of working with the Px Group for three years. Together we developed the first direct to patient marketing campaign that helped patients with a rare disease recognize their symptoms and empowered them to self- identify to their health care practitioners. Their attention to detail, and intimate knowledge of the patient ecosystem ensured that the program helped raise awareness and understanding of a disease that often goes undiagnosed for years."
"The Px Group is a true partner and delivers unrivaled expertise in understanding what’s important for patients suffering with rare and devastating diseases. The Px Group offers new ideas and novel solutions focused on the unique experiences of patients suffering with rare disease that you just can’t get with the bigger, cookie cutter agencies. "
"The account team at Px Group is second to none and is equally passionate and dedicated as we are. As a biopharmaceutical company that’s committed to transforming the lives of patients with rare diseases, Px is a trusted partner that has made a meaningful difference in helping us achieve our mission."